These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

158 related items for PubMed ID: 4140573

  • 21. [New approaches to therapy in glomerulonephritis patients].
    Riabov SI, Rakitianskaia IA, Stavskaia VV, Nikitina NA.
    Ter Arkh; 1996; 68(6):24-7. PubMed ID: 8771678
    [Abstract] [Full Text] [Related]

  • 22. [Treatment of diffuse membranous glomerulonephritis with a combination of anticoagulants and corticosteroids].
    Belovezhdov N.
    Vutr Boles; 1984; 23(5):59-67. PubMed ID: 6523843
    [Abstract] [Full Text] [Related]

  • 23. [Polymorphism studies of angiotensin converting enzyme gene in chronic glomerulonephritis].
    Kutyrina IM, Tareeva IE, Nosikov VV, Kamyshova ES, Gorashko NM, Chistiakov DA, Okonova EB, Troepol'skaia OV.
    Ter Arkh; 1999; 71(6):30-4. PubMed ID: 10420452
    [Abstract] [Full Text] [Related]

  • 24. [The effect of steroid's preparations, doses and administration methods on the suppression of adrenocortical functions during corticosteroid therapy in chronic diseases (author's transl)].
    Morimoto Y, Hanasaki N, Miyatake A, Nakao K, Noma K, Yagura T, Yamamura Y, Arisue K, Tachibana T, Yano S.
    Nihon Naika Gakkai Zasshi; 1978 Jan; 67(1):57-68. PubMed ID: 632638
    [No Abstract] [Full Text] [Related]

  • 25. [Effects of pathogenetic therapy on blood cholesterol in patients with glomerulonephritis].
    Neverov NI, Stavrovskaia EV, Kolina IB, Shvetsov MIu, Zakharova EV, Shilov EM.
    Ter Arkh; 2001 Jan; 73(6):37-40. PubMed ID: 11521519
    [Abstract] [Full Text] [Related]

  • 26. [Treatment of oligo-anuric forms of acute glomerulonephritis].
    Zosin C, Mănescu N.
    Med Interna (Bucur); 1973 Jun; 25(6):667-76. PubMed ID: 4793938
    [No Abstract] [Full Text] [Related]

  • 27. [Indications and effectiveness of combined therapy in chronic glomerulonephritis].
    Ratner MIa, Biriukova LS, Makurov AI.
    Ter Arkh; 1987 Jun; 59(8):29-34. PubMed ID: 3686442
    [No Abstract] [Full Text] [Related]

  • 28. [Comparison of two cyclophosphamide treatment regimens in nephrotic patients with chronic glomerulonephritis].
    Krasnova TN, Shilov EM, Tareeva IE, Gordovskaia NB, Lavrova ON, Miroshnichenko NG, Troepol'skaia OV, Ivanova LV, Ivanov AA.
    Ter Arkh; 1998 Jun; 70(6):14-7. PubMed ID: 9695216
    [Abstract] [Full Text] [Related]

  • 29. [Corticosteroid hormones in the treatment of chronic lympholeukosis].
    Miansarian IT.
    Zh Eksp Klin Med; 1967 Jun; 7(2):70-7. PubMed ID: 4303393
    [No Abstract] [Full Text] [Related]

  • 30. [Changes in several indices of renal hemodynamics during hormone therapy of chronic glomerulonephritis].
    Pyrig LA, Fursova NIa.
    Vrach Delo; 1971 Dec; 12():11-3. PubMed ID: 5137848
    [No Abstract] [Full Text] [Related]

  • 31. [Our experience with corticosteroid therapy of nephritis].
    Cuppini R, Carotti A, Guidi A.
    Minerva Med; 1966 Mar 07; 57(19):802-10. PubMed ID: 5908616
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. [Comparative evaluation of the effectiveness of treatment of chronic diffuse glomerulonephritis].
    Riabov SI, Blozshteĭn IG, Diskina DB, Zhdanova LD, Minkin RB.
    Ter Arkh; 1976 Mar 07; 48(7):100-7. PubMed ID: 996735
    [No Abstract] [Full Text] [Related]

  • 35. [Treatment of various clinico-morphological variants of chronic glomerulonephritis].
    Tomilina NA, Biriukova LS, Makurov AI, Ratner MIa.
    Ter Arkh; 1983 Mar 07; 55(6):61-6. PubMed ID: 6612622
    [No Abstract] [Full Text] [Related]

  • 36. The effects of azathioprine and prednisolone on T- and B-lymphocytes in patients with lupus nephritis and chronic glomerulonephritis.
    Tareyeva IE, Shilov EM, Gordovskaya NB.
    Clin Nephrol; 1980 Nov 07; 14(5):233-7. PubMed ID: 6971722
    [Abstract] [Full Text] [Related]

  • 37. [Factors influencing the results of chronic glomerulonephritis treatment].
    Riabov SI, Stavskaia VV, Chistova EK, Ashkinazi RI, Zaitseva NI, Kravchenko NP, Mozgovaia AN, Sashurina SN.
    Klin Med (Mosk); 1997 Nov 07; 75(2):38-42. PubMed ID: 9157214
    [Abstract] [Full Text] [Related]

  • 38. [Blood phospholipids in patients with different clinical manifestations of chronic glomerulonephritis and preserved kidney function].
    Riabov SI, Kulikova AI, Mitrofanova OV.
    Ter Arkh; 1995 Nov 07; 67(2):51-4. PubMed ID: 7725261
    [No Abstract] [Full Text] [Related]

  • 39. [Experience in the use of valsartan with the aim to inhibit progression of kidney failure in patients with chronic glomerulonephritis].
    Shvetsov MIu, Medvedeva TIu, Kozlovskaia NL, Miroshnichenko NG, Okonova EB, Shonichev DG, Rudenko TE, Stavrovskaia EV, Plieva OK.
    Ter Arkh; 2001 Nov 07; 73(6):55-61. PubMed ID: 11521525
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 8.